Not currently recruiting at UCSF
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Summary
- Eligibility
- for people ages 2-17 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT05265273
- Phase
- Phase 2/3 Myasthenia Gravis Research Study
- Study Type
- Interventional
- Participants
- Expecting 12 study participants
- Last Updated